Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Return on Capital Employed (2021 - 2025)

PAVmed has reported Return on Capital Employed over the past 5 years, most recently at 0.92% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.92% for Q4 2025, down 741.0% from a year ago — trailing twelve months through Dec 2025 was 0.92% (down 741.0% YoY), and the annual figure for FY2025 was 1.1%, down 1360.0%.
  • Return on Capital Employed for Q4 2025 was 0.92% at PAVmed, down from 0.66% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PAVM hit a ceiling of 11.57% in Q3 2023 and a floor of 10.11% in Q1 2023.
  • Median Return on Capital Employed over the past 5 years was 0.94% (2021), compared with a mean of 0.27%.
  • Peak annual rise in Return on Capital Employed hit 1400bps in 2023, while the deepest fall reached -914bps in 2023.
  • PAVmed's Return on Capital Employed stood at 0.95% in 2021, then crashed by -337bps to 4.14% in 2022, then surged by 200bps to 4.14% in 2023, then skyrocketed by 57bps to 6.49% in 2024, then crashed by -114bps to 0.92% in 2025.
  • The last three reported values for Return on Capital Employed were 0.92% (Q4 2025), 0.66% (Q3 2025), and 0.77% (Q2 2025) per Business Quant data.